New Zealand National Trauma Network and Dendrite launch new national trauma registry

The New Zealand National Trauma Network and Dendrite Clinical Systems have launched a new national trauma registry in the country. The ‘National Trauma Registry’ will collect and record data on approximately 2,400 patients who suffer major trauma in New Zealand every year. By recording and analysing data, trauma experts will be able to examine the quality of care provided and assess whether the system as a whole or individual regions, hospitals/centres are performing to an accepted standard and, if necessary, initiate quality improvements.
“We are delighted to launch the New Zealand National Trauma Registry, which utilises our international web-registry software platform. By collecting and recording data on major trauma, researchers will be able examine the treatment of every patient and, where appropriate, recommended changes to improve clinical outcomes,” said Dr Peter Walton, Managing Director of Dendrite Clinical Systems.
“The previous national registry was built for the American market and certain aspects were irrelevant to our needs, too complex and the data was not readily accessible. Hospitals and regions could not access their data on a day-to-day basis,” explained Professor Ian Civil, Clinical Leader of the National Trauma Network. “We wanted a minimum dataset that was much smaller and simpler, data that was accessible in ‘real-time’ and easily extracted. Dendrite’s software has provided us with a registry that is simple to use and allows users to not only see their data, but also the real-time data for the whole region. The registry has allowed a relatively small group of users – but geographically isolated from each other – to feel much more part of a single group and feel connected.”
This new national registry collates data from 74 separate fields of information describing the course of a trauma patient’s progress through the system - from the time of injury and hospital stay, to their discharge. This includes a variety of process measures such as whether they had a CT-scan, how long before they were sent to ICU, whether they were ventilated, vital signs on admission and during their stay, what were their injuries (using the Injury Severity Score) etc.
“I think the registry is a remarkable implementation and deployment achievement considering it was developed during the most intense period of the coronavirus outbreak in the UK. The fact we were able to launch the registry on time is a great testament to the organisation of the company and the professionalism of its staff,” Professor Civil added. “It has been a pleasure to work with Peter Walton and Dendrite’s software team of engineers, they have been incredibly committed to the project through the whole process and I would certainly recommend Dendrite to anyone looking to develop a clinical registry or database.”
As well as the National Trauma Registry, Dendrite has developed the New Zealand National Adult Cardiac Surgery Registry and the New Zealand National Breast Cancer Registry, and the company has several hospital installations in Auckland, Hamilton, Wellington and Christchurch. In addition, following an open global tendering process Dendrite was awarded the contract to develop a major Multi-Disciplinary Meeting (MDM) system for managing cancer patients across the Midland Region of New Zealand and this has just been launched live very successfully.
The New Zealand National Trauma Network will continue to publish annual reports from the data collected by the New Zealand National Trauma Registry. To view the annual reports, please click here
To learn more about the New Zealand National Trauma Registry, please click here
To learn more about the New Zealand National Trauma Network, please click here
To learn more about Dendrite contact peter.walton@e-dendrite.com
Sapphire Medical Clinics and Dendrite Clinical Systems have launched the UK Medical Cannabis Registry, an initiative that is designed to rapidly expand the evidence base for medical cannabis in the UK and decrease the cost of access for patients. The launch will collect and analyse clinical information on patients taking medical cannabis treatments for all recognised eligible conditions.
“I am very pleased to report that demand for the Dendrite Web-Registry platform has reached an all-time high” Dr Peter Walton, Managing Director of Dendrite Clinical System. “We’re receiving new orders for new national and international registries every few days now – for surgical registries, medical registries, rare disease registries, medical device registries and Coronavirus Registries (for a range of Community, National, International and Global Covid-19 Registries).”
Sapphire Medical Clinics and Dendrite Clinical Systems have established the UK’s first national UK’s first comprehensive medical cannabis patient registry - UK Medical Cannabis Registry. The UK Medical Cannabis Registry will be the first of its kind covering all conditions for which there is evidence of clinical efficacy of medical cannabis. The formation of the registry means that real world evidence, cited as a key barrier to wider patient prescriptions by NHS England, will now be available on request to the medical community for analysis.
The British Association of Plastic, Reconstructive and Aesthetic Surgeons (BAPRAS), in conjunction with Dendrite Clinical Systems, is delighted to announce the release of the First UK National Flap Registry (UKNFR) Report. The UKNFR, which was launched in August 2015, collects information on all major free and pedicled flap operations carried out in the UK.
Dendrite Clinical Systems, the publisher of Bariatric News, has announced the publication of the Bariatric News Industry and Product Guide 2019 – a comprehensive A-Z guide to companies, products and services within the bariatric and metabolic specialty.
Dendrite Clinical Systems, the publisher of Bariatric News, is pleased to announce issue 39 of the newspaper is now available to view/download. The newspaper reports on research, technology, events and policy in the bariatric specialty, the latest clinical studies, policy changes and product news, the latest meetings and events, interviews prominent bariatric experts, and host debates between specialists on controversial topics.


